Post a Free Blog

Submit A Press Release

Thursday, March 28, 2024
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Truck Series (TRUCK)
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
-- Advertisement --spot_img
HomeBusinessPfizer Covid-19 vaccines sales $7.8 billion in Q2: Raises guidance on vaccine...

Pfizer Covid-19 vaccines sales $7.8 billion in Q2: Raises guidance on vaccine sales in 2021

 

On Wednesday, Pfizer has released its second quarter results and said that its Covid shots brought in $7.8 billion. It has also raised its sales forecast for the vaccines from $26 billion to $33.5 billion in 2021. It has exceeded Wall Street’s expectations on both earnings and revenue. The company said that it estimates its adjusted pretax profit for the vaccine to be 20 percent. The company’s shares increased by 2.5 percent, intraday trading.

 

According to average expectations by analysts and compiled by Refintiv:

 

  • The adjusted earnings per share were $1.07 while the projected earnings were 97 cents.
  • The revenue stood at $18.98 billion while the estimated revenue was 18.74.

 

Pfizer has also changed its estimates of its full year earnings. It is now looking at earnings of $3.95 to $4.05 per share from its earlier forecast of $3.55 to $3.65 per share. It has also raised its revenue estimates from $78 billion to $80 billion from previous forecasts of $70.5 billion to $72.5 billion.

 

Other units of Pfizer also saw a rise in sales. The oncology unit revenue increased by 19 percent year over year and stood at $3.1 billion. Its hospital unit soared 21 percent when compared with last year and brought in a revenue of $2.2 billion, while its internal medicine unit grew by a modest 5 percent from last year and generated $2.4 billion.

 

As the delta variant spreads across the nation, Pfizer has been peddling its booster shot to the government, but the Centers for Disease Control and Prevention (CDC) has not taken a decision on such shots though it may consider it for vulnerable people.

 

In his post-earnings conference call on Wednesday, Pfizer’s CEO Albert Bourla said that some people might need a third shot “earlier” than a year to maintain the highest possible protection against the virus. The company is looking emergency use authorization for its booster shot from the Food and Drug Administration as early as August. By early next year Pfizer is also expecting to get full approval for its two dose COVID-19 vaccine manufactured in collaboration with BioNTech, in Germany.

Image Marco Verch Professional  

Click Here For Full Stock Research on Pfizer by CWEB

Subscribe to get Latest News Updates

Latest News Articles

You may like more
more

Robinhood Gains 3 percent on Credit Card Launch Plans

Robinhood Markets (NASDAQ:HOOD) stock rose more than 3% intra-day...

Bloom Energy’s Price Target Cut at Susquehanna

Susquehanna analysts adjusted their price target for Bloom Energy...

Nio Shares Drops 6 percent Following Slashed Q1 Delivery Outlook

NIO (NYSE:NIO) shares fell more than 6% intra-day today...

nCino Shares Jump 19 percent Following Q4 Earnings

nCino (NASDAQ:NCNO) shares surged more than 19% intra-day today...